GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » Short Percentage of Float

Klaria Pharma Holding AB (STU:6FN) Short Percentage of Float


View and export this data going back to 2021. Start your Free Trial

What is Klaria Pharma Holding AB Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Klaria Pharma Holding AB's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Klaria Pharma Holding AB's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Klaria Pharma Holding AB's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Klaria Pharma Holding AB's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Klaria Pharma Holding AB's Short Percentage of Float falls into.


;
;

Klaria Pharma Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Klaria Pharma Holding AB (STU:6FN) » Definitions » Short Percentage of Float
Comparable Companies
XSAT:ACUC OSTO:ERMA OSTO:VIVE OSTO:TOL OSTO:NANEXA OSTO:NEWBRY XSAT:ODI XSAT:PMED OSTO:GABA XSAT:DANCAN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
KLAR:Sweden
Address
Virdings Alle 2, Uppsala, SWE, 754 50
Website
https://www.klaria.com
Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film. Majority of the group's operations are conducted in Sweden.

Klaria Pharma Holding AB Headlines

No Headlines